RCEL - RCEL Investor Notice: Levi & Korsinsky Investigates AVITA Medical, Inc. for Securities Law Violations

New York, New York--(Newsfile Corp. - August 28, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of AVITA Medical, Inc. ("AVITA Medical, Inc.") (NASDAQ: RCEL) concerning possible violations of federal securities laws.

AVITA reported second quarter 2025 results and revised its 2025 guidance, stating that the Company experienced a "significant headwind from a temporary gap in Medicare Administrative Contractor (MAC) payments to providers for the use of our flagship RECELL® System, which led to a weakening in demand. Multiple MACs initiated payments in July with resolution expected in Q3."

Following this report, the price of the Company's stock dropped on August 7, 2025. To obtain additional information, go to:

https://zlk.com/pslra-1/avita-medical-inc-lawsuit-submission-form?prid=164287&wire=5&utm_campaign=63

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212)363-7500.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/264358